What is AbbVie's approach to partnering in the drug delivery space? Large pharma pipelines are becoming more diverse in terms of different modalities, product presentations, and challenges with ...

The drug delivery devices market offers opportunities in self-administration, home healthcare, and biologics due to rising chronic diseases. North America dominates this growing market with advanced ...

Oral Drug Delivery Technology Market OverviewThe global oral drug delivery technology market is projected to expand steadily over the coming years, with an estimated growth rate of around 7% during ...

Malaria remains a major global health burden, and the continued emergence of resistance to frontline therapies, including artemisinin-based combination ...

An international collaboration between researchers at The Centre for Programmable Matter at Durham University (U.K.) and the Malopolska Centre of Biotechnology, Jagiellonian University (Poland) has ...

Drug delivery has undergone a remarkable transformation from basic oral tablets to sophisticated, targeted systems that deliver treatments with unprecedented precision. Today's pharmaceutical ...

Elastin-like polypeptides (ELPs) are recombinant biopolymers that mimic the unique properties of natural elastin, offering precise control over molecular weight, sequence and thermal responsiveness.

A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases. At the Wits Advanced Drug Delivery Platform (WADDP), postdoctoral researcher Dr.

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, posing a major challenge to health systems. There are a variety of ...